Similar articles

• Dopamine Receptor D1 Agonism and Antagonism Using a Field-Effect Transistor Assay.

  Park SJ, Yang H, Lee SH, Song HS, Park CS, Bae J, Kwon OS, Park TH, Jang J. Park SJ, et al. ACS Nano. 2017 Jun 27;11(6):5950-5959. doi: 10.1021/acsnano.7b01722. Epub 2017 Jun 7. ACS Nano. 2017. PMID: 28558184
• Screening and isolation of a natural dopamine D1 receptor antagonist using cell-based assays.

  Yu S, Park JS, Paredes V, Song MC, Baek NI, Lee SI, Lim JS, Cho NY, Yoon J, Baek K. Yu S, et al. J Biotechnol. 2010 Feb 1;145(3):304-9. doi: 10.1016/j.jbiotec.2009.12.005. Epub 2009 Dec 4. J Biotechnol. 2010. PMID: 19963021
• Design and discovery of 1,3-benzodiazepines as novel dopamine antagonists.

  Zhu Z, Sun ZY, Ye Y, McKittrick B, Greenlee W, Czarniecki M, Fawzi A, Zhang H, Lachowicz JE. Zhu Z, et al. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5218-21. doi: 10.1016/j.bmcl.2009.07.012. Epub 2009 Jul 9. Bioorg Med Chem Lett. 2009. PMID: 19643610
• CNS distribution of D1 receptors: use of a new specific D1 receptor antagonist, [3H]SCH39166.

  Wamsley JK, Alburges ME, McQuade RD, Hunt M. Wamsley JK, et al. Neurochem Int. 1992 Mar;20 Suppl:123S-128S. doi: 10.1016/0197-0186(92)90224-f. Neurochem Int. 1992. PMID: 1365410 Review.
• Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.

  Braun AR, Laruelle M, Mouradian MM. Braun AR, et al. J Neural Transm (Vienna). 1997;104(4-5):341-62. doi: 10.1007/BF01277656. J Neural Transm (Vienna). 1997. PMID: 9295170 Review.